This is the authors' abstract. We don't add key points for this paper.
The current COVID-19 pandemic has created a havoc with rapidly increasing morbidity and mortality rates globally. To tide over the current circumstances, it is imperative that novel vaccines are developed at the earliest. Development of a novel vaccine against SARS-Co-V-2 seems to be a daunting task at the moment. We will have to wait at least for a year before any such vaccine enters the global market. Issues pertaining to vaccine efficacy and safety remain unanswered at the moment. We are hopeful that the ongoing research on this mysterious virus will unearth valuable information in the days to come, which will help us develop most suitable treatment options and vaccine platforms respectively.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bhatia et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: